Home
>
National Drug Code (NDC)
>
Oxaprozin
Oxaprozin - 57664-391-13 - (Oxaprozin)
Drug Information of Oxaprozin
| Product NDC: | 57664-391 |
| Proprietary Name: | Oxaprozin |
| Non Proprietary Name: | Oxaprozin |
| Active Ingredient(s): | 600 mg/1 & nbsp; Oxaprozin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Oxaprozin
| Product NDC: | 57664-391 |
| Labeler Name: | Caraco Pharmaceutical Laboratories, Ltd. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075844 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20020103 |
Package Information of Oxaprozin
| Package NDC: | 57664-391-13 |
| Package Description: | 500 TABLET in 1 BOTTLE (57664-391-13) |
NDC Information of Oxaprozin
| NDC Code | 57664-391-13 |
| Proprietary Name | Oxaprozin |
| Package Description | 500 TABLET in 1 BOTTLE (57664-391-13) |
| Product NDC | 57664-391 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Oxaprozin |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20020103 |
| Marketing Category Name | ANDA |
| Labeler Name | Caraco Pharmaceutical Laboratories, Ltd. |
| Substance Name | OXAPROZIN |
| Strength Number | 600 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
